Advanced Search
Article Contents
ABOUT THIS ARTICLE
The Innovation Medicine > 2024 Vol. 2 > No. 2 > 100071
Next Article Previous Article
COMMENTARY   Open Access     Cite

Chronic active SARS-CoV-2 in B-cell immunodeficiency

  • 1.

    National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China

More Information
  • Corresponding author: caobin_ben@163.com
  • Received Date:  March 18, 2024
    Accepted Date:  May 01, 2024
    Published Online:  May 08, 2024
The Innovation Medicine  2(2),  https://doi.org/10.59717/j.xinn-med.2024.100071  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] Ghafari, M., Hall, M., Golubchik, T., et al. (2024). Prevalence of persistent SARS-CoV-2 in a large community surveillance study. Nature 626: 1094−1101. DOI: 10.1038/s41586-024-07029-4.

    View in Article CrossRef Google Scholar Scopus

    [2] DeWolf, S., Laracy, J.C., Perales, M.A., et al. (2022). SARS-CoV-2 in immunocompromised individuals. Immunity 55: 1779−1798. DOI: 10.1016/j.immuni.2022.09.006.

    View in Article CrossRef Google Scholar Scopus

    [3] Lyudovyk, O., Kim, J.Y., Qualls, D., et al. (2022). Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses. Cancer Cell 40 : 738-753 e735. DOI: 10.1016/j.ccell.2022.05.013.

    View in Article Google Scholar

    [4] Wang, S.Y., Wang, Y.M., Liu, M., et al. (2023). Migratory pulmonary ground glass opacities caused by SARS-CoV-2 infection in a patient on B-cell depletion therapy. Zhonghua Jie He He Hu Xi Za Zhi 46: 1233−1239. DOI: 10.3760/cma.j.cn112147-20230809-00061.

    View in Article CrossRef Google Scholar

    [5] Machkovech, H.M., Hahn, A.M., Garonzik Wang, J., et al. (2024). Persistent SARS-CoV-2 infection: Significance and implications. Lancet Infect. Dis. 24: e453−e462. DOI: 10.1016/S1473-3099(23)00815-0.

    View in Article CrossRef Google Scholar

    • Cited by

  • Cite this article:

    Xu J., Zhang H., Wang Y., et al., (2024). Chronic active SARS-CoV-2 in B-cell immunodeficiency. The Innovation Medicine 2(2): 100071. https://doi.org/10.59717/j.xinn-med.2024.100071
    Xu J., Zhang H., Wang Y., et al., (2024). Chronic active SARS-CoV-2 in B-cell immunodeficiency. The Innovation Medicine 2(2): 100071. https://doi.org/10.59717/j.xinn-med.2024.100071

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF
Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(3034) PDF downloads(1264)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    {{newsColumn.name}}

    Stay connected

    {{newsColumn.name}}

    Website copyright © Innovation Press. Published articles are licensed under CC BY with copyright retained by the authors.